Last reviewed · How we verify
NCT04852315: CAFFFUTSAL
Acute Caffeine Ingestion on Futsal Performance
NA trial testing Caffeine in Caffeine in 16 participants. Completed in 18 October 2019.
18 October 2019
Quick facts
| Lead sponsor | Universidad Francisco de Vitoria |
|---|---|
| Phase | NA |
| Status | Completed |
| Study type | INTERVENTIONAL |
| Allocation | randomized |
| Design | crossover |
| Masking | quadruple |
| Primary purpose | treatment |
| Enrollment | 16 |
| Start date | 16 October 2019 |
| Primary completion | 18 October 2019 |
| Estimated completion | 18 October 2019 |
| Sites | 1 location across Spain |
Drugs / interventions tested
- Caffeine (caffeine) — full drug profile →
- Placebo
Conditions studied
Sponsor
Universidad Francisco de Vitoria — full company profile →
Who can join
Adults 18 to 35, male only, with Caffeine or Placebo. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
Caffeine supplementation has been recognized such as an useful strategy for improving performance in intermittent sports, however caffeine ingestion in futsal has been barely studied. In this randomized placebo-controlled study, we investigated the effects of acute caffeine supplementation in improving neuromuscular performance and physical match activity in futsal players.
Publications & conference data
1 peer-reviewed publication reference this trial (live from Europe PMC):
-
Effects of acute caffeine ingestion on futsal performance in sub-elite players.
López-Samanes Á, Moreno-Pérez V, Travassos B, Del Coso J. · · 2021 · cited 18× · PMID 34132880 · DOI 10.1007/s00394-021-02617-w
Verify or expand the search:
- PubMed search for NCT04852315
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other trials of Caffeine
Trials testing the same drug.
- NCT07456670 — Caffeine for Infants Born at 28 to 34 Weeks Receiving Respiratory Support · Phase 2 · not yet recruiting
- NCT07520864 — Effects of Caffeine on Elite Weightlifting Performance · NA · completed
- NCT07479875 — Caffeine Supplementation and Strength Endurance in Brazilian Jiu-jitsu Athletes · NA · completed
- NCT07466732 — Effects of Caffeine Ingestion on Morning Cognitive and Muscle Repeated Sprint Performance in Males · EARLY_PHASE1 · enrolling by invitation
- NCT07458594 — Combined Caffeine and Rhodiola Rosea on Aerial Duel Performance in Soccer · NA · completed
Other recruiting trials for Caffeine
Currently open trials in the same condition.
- NCT07469852 — Effects of Caffeine Ingestion on Morning Cognitive and 4-km Time Trial Performance in Males · Phase 1, PHASE2 · active not recruiting
- NCT07404254 — Effects of Variations in Caffeinated Beverages on Well-being · NA · recruiting
- NCT06763172 — Effects of Caffeine on Reinforcement Learning in Healthy Adults Using PET/MRI · Phase 4 · recruiting
- NCT05325502 — Does Caffeine Facilitate Human Reward Learning Behaviors? · NA · active not recruiting
- NCT05454332 — The Caffeine Therapy in the Fetal to Neonatal Transition · Phase 4 · recruiting
Other Universidad Francisco de Vitoria trials
Trials by the same sponsor.
- NCT07506343 — SDT-Based Intervention for Exercise Motivation in Female Students · NA · not yet recruiting
- NCT07452237 — Effects of Transcutaneous Neuromodulation and Cervical Exercise in Students With Chronic Nonspecific Cervical Pain · NA · not yet recruiting
- NCT07400900 — Effectiveness of a Standardised Stabilisation Exercise Protocol in Volleyball Players With Non-traumatic Shoulder Instab · NA · not yet recruiting
- NCT07334171 — Inspiratory Muscle Strength and Diaphragm Thickness in People With Shoulder Pain in Tennis Players · active not recruiting
- NCT07328334 — Longitudinal Assessment of Maximal Inspiratory Pressure and Functional Capacity Following Inspiratory Muscle Training in · NA · not yet recruiting
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT04852315 (US National Library of Medicine, public domain)
- Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Universidad Francisco de Vitoria
- Last refreshed: 21 April 2021
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04852315.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing